Bronwyn Brophy is appointed new CEO of Vitrolife AB (publ)
We are excited to announce that Bronwyn Brophy has been appointed as the new CEO for Vitrolife Group.
Bronwyn Brophy has an impressive track record as a leader of global Life science and Medtech businesses, such as Thermo Fisher Scientific, Medtronic and Johnson & Johnson. The last years within Thermo Fischer, Bronwyn Brophy was heading the Immunodiagnostics Division globally and before that served as President of the EMEA region. She will join the company at the latest on 1 August 2023.
Bronwyn Brophy comments the appointment: “I am very honored to the appointment as new CEO of Vitrolife. I believe the company has a very exciting future with great growth potential with strong distributors and global partners”.’
Read the full press release here: https://lnkd.in/dwmkAvqN